Mairinger, F. D., Vollbrecht, C., Flom, E., Christoph, D. C., Schmid, K., Kollmeier, J., . . . Henry Walter, R. F. (2017). Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma. Oncotarget.

Mairinger, Fabian Dominik, Claudia Vollbrecht, Elena Flom, Daniel Christian Christoph, Kurt-Werner Schmid, Jens Kollmeier, Helmut Hans Popper, Thomas Mairinger, et Robert Fred Henry Walter. "Folic Acid Phenotype (FAP) Is a Superior Biomarker Predicting Response to Pemetrexed-based Chemotherapy in Malignant Pleural Mesothelioma." Oncotarget 2017.

Mairinger, Fabian Dominik, et al. "Folic Acid Phenotype (FAP) Is a Superior Biomarker Predicting Response to Pemetrexed-based Chemotherapy in Malignant Pleural Mesothelioma." Oncotarget 2017.